Order Article Reprints

Baraibar I, Roman M, Rodríguez-Remírez M, López I, Vilalta A, Guruceaga E, Ecay M, Collantes M, Lozano T, Alignani D, et al. Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8⁺ T Cells. Cancers. 2020; 12(11):3169. https://doi.org/10.3390/cancers12113169

Baraibar, Iosune, Marta Roman, María Rodríguez-Remírez, Inés López, Anna Vilalta, Elisabeth Guruceaga, Margarita Ecay, María Collantes, Teresa Lozano, Diego Alignani, and et al. 2020. "Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8⁺ T Cells" Cancers 12, no. 11: 3169. https://doi.org/10.3390/cancers12113169

Baraibar, I., Roman, M., Rodríguez-Remírez, M., López, I., Vilalta, A., Guruceaga, E., Ecay, M., Collantes, M., Lozano, T., Alignani, D., Puyalto, A., Oliver, A., Ortiz-Espinosa, S., Moreno, H., Torregrosa, M., Rolfo, C., Caglevic, C., García-Ros, D., Villalba-Esparza, M., ... Gil-Bazo, I. (2020). Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8⁺ T Cells. Cancers, 12(11), 3169. https://doi.org/10.3390/cancers12113169